BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25924621)

  • 21. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
    Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
    Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
    Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
    Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Grb2-associated binder 1 is essential for cardioprotection against ischemia/reperfusion injury.
    Sun L; Chen C; Jiang B; Li Y; Deng Q; Sun M; An X; Yang X; Yang Y; Zhang R; Lu Y; Zhu DS; Huo Y; Feng GS; Zhang Y; Luo J
    Basic Res Cardiol; 2014 Jul; 109(4):420. PubMed ID: 24951957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
    Abwainy A; Babiker F; Akhtar S; Benter IF
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H104-12. PubMed ID: 26519026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
    Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
    Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Key role of endothelium in the eNOS-dependent cardioprotection with exercise training.
    Farah C; Nascimento A; Bolea G; Meyer G; Gayrard S; Lacampagne A; Cazorla O; Reboul C
    J Mol Cell Cardiol; 2017 Jan; 102():26-30. PubMed ID: 27866931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats.
    Lin C; Sui H; Gu J; Yang X; Deng L; Li W; Ding W; Li D; Yang Y
    Microvasc Res; 2013 Nov; 90():162-8. PubMed ID: 23988878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoprotective and proangiogenic activity of ex-vivo netrin-1 transgene overexpression protects the heart against ischemia/reperfusion injury.
    Durrani S; Haider KH; Ahmed RP; Jiang S; Ashraf M
    Stem Cells Dev; 2012 Jul; 21(10):1769-78. PubMed ID: 21936706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway.
    Robinet A; Millart H; Oszust F; Hornebeck W; Bellon G
    FASEB J; 2007 Jul; 21(9):1968-78. PubMed ID: 17341689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.
    Vladic N; Ge ZD; Leucker T; Brzezinska AK; Du JH; Shi Y; Warltier DC; Pratt PF; Kersten JR
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2130-9. PubMed ID: 21908789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thioredoxin Uses a GSH-independent Route to Deglutathionylate Endothelial Nitric-oxide Synthase and Protect against Myocardial Infarction.
    Subramani J; Kundumani-Sridharan V; Hilgers RH; Owens C; Das KC
    J Biol Chem; 2016 Nov; 291(45):23374-23389. PubMed ID: 27587398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway.
    Xuan YT; Guo Y; Zhu Y; Wang OL; Rokosh G; Bolli R
    Circulation; 2007 Jul; 116(5):535-44. PubMed ID: 17606840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.
    Luo T; Chen B; Zhao Z; He N; Zeng Z; Wu B; Fukushima Y; Dai M; Huang Q; Xu D; Bin J; Kitakaze M; Liao Y
    Basic Res Cardiol; 2013 May; 108(3):342. PubMed ID: 23467745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological postconditioning treatment of myocardial infarction with netrin-1.
    Bouhidel JO; Wang P; Li Q; Cai H
    Front Biosci (Landmark Ed); 2014 Jan; 19(3):566-70. PubMed ID: 24389204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saffron (Crocus sativus) intake provides nutritional preconditioning against myocardial ischemia-reperfusion injury in Wild Type and ApoE
    Efentakis P; Rizakou A; Christodoulou E; Chatzianastasiou A; López MG; León R; Balafas E; Kadoglou NPE; Tseti I; Skaltsa H; Kostomitsopoulos N; Iliodromitis EK; Valsami G; Andreadou I
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):919-929. PubMed ID: 28964663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor regulation of endothelial nitric oxide synthase phosphorylation is involved in isoflurane cardiac preconditioning.
    Liu Y; Paterson M; Baumgardt SL; Irwin MG; Xia Z; Bosnjak ZJ; Ge ZD
    Cardiovasc Res; 2019 Jan; 115(1):168-178. PubMed ID: 29931049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.